Crewe Advisors’s Prothena Corp PRTA Stock Holding History

Crewe Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-52	Closed	-$3K	–	1202
2022 Q3	$3K	Buy	+52	New	+$1.64K	﹤0.01%	979

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Crewe Advisors's PRTA Position: Q4 2022 in Review

Crewe Advisors sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 52 shares — an estimated $3K sold.

Crewe Advisors first reported a position in PRTA in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

Crewe Advisors reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 52 Prothena Corp shares in Q4 2022, an estimated $3K.
Crewe Advisors first reported a position in Prothena Corp in Q3 2022 and held it in 1 quarter.
Crewe Advisors's Prothena Corp position peaked at $3K in Q3 2022.
201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.